The news that the FDA is now labeling the cyclospora finding at Taylor Farms as a “false positive” has me sitting here in total disbelief. As someone who looks at these kinds of regulatory announcements with a healthy dose of skepticism, I simply don’t buy it. You don’t just announce a potential contamination that triggers massive public concern, carries the weight of a major food safety issue, and could force a massive, costly recall without having your ducks in a row first. My gut tells me something much more sinister—or at the very least, much more incompetent—is going on behind the scenes here.… Continue reading
It’s quite unsettling to learn that a sample of iceberg lettuce, supplied by Taylor Farms, has tested positive for the parasite linked to the current US outbreak. What makes this particularly concerning is that this positive sample wasn’t even part of the product recall list. This situation highlights a deeper issue, especially when considering how Taco Bell, which has faced scrutiny in the past for making people sick, appears to be taking proactive steps while larger entities seem to be lagging. It’s almost as if a fast-food chain is outperforming governmental agencies in safeguarding public health.
The fact that this parasite has spread to other restaurant chains, not just Taco Bell, is a stark reminder of the pervasive nature of foodborne illnesses.… Continue reading
Despite growing scientific evidence and the EPA identifying food as the primary source of exposure, the US Food and Drug Administration has refused a legal petition to set limits on toxic PFAS “forever chemicals” in food. This decision marks a setback for public health advocates, as PFAS are linked to numerous serious health issues and are widely present in the food system due to their use in packaging, pesticides, and processing. While the FDA acknowledges plans to establish action levels, these are not legally binding and may not lead to contaminated food removal, prompting legal challenges from advocacy groups seeking court-ordered thresholds.
Read More
The U.S. Food and Drug Administration has authorized Philip Morris to market 20 variants of its Zyn nicotine pouches with claims of reduced harm compared to cigarettes. This clearance, based on the assertion that Zyn use lowers the risk of various tobacco-related diseases, allows for marketing these products as beneficial to individual users and the public’s health. The decision comes as nicotine pouches represent the fastest-growing nicotine product in the U.S., experiencing significant sales increases for Philip Morris.
Read More
The Food and Drug Administration has authorized fruit-flavored electronic cigarettes for adult smokers, marking a significant shift in policy following industry appeals. This decision, which permits mango and blueberry flavors, contrasts with previous restrictions that favored only tobacco and menthol options. The FDA cites a company’s digital age-verification system as a measure to prevent underage access, though health groups remain concerned about youth uptake. This authorization is considered a key test case as teen vaping rates decline and manufacturers advocate for looser regulations.
Read More
It’s quite concerning when the very institutions tasked with safeguarding public health appear to be obstructing the dissemination of scientific findings, especially when those findings suggest positive outcomes related to vaccines. The idea that research demonstrating the safety and even beneficial long-term effects of both COVID-19 and shingles vaccines might have been deliberately held back by the F.D.A. is deeply troubling and warrants a closer look.
When we talk about vaccines, particularly the shingles vaccine, the consensus among those who have experienced the illness is overwhelmingly in favor of inoculation. It’s a two-shot series, and both are crucial for full efficacy.… Continue reading
The Food and Drug Administration (FDA) has refused to review Moderna’s experimental flu shot, mRNA-1010, citing issues with the study design despite previous agency approval. Moderna stated the FDA did not identify any safety or efficacy concerns and plans to meet with the agency to discuss a path forward. This decision, which contrasts with prior feedback, occurs amidst broader shifts in U.S. vaccine regulation influenced by prominent vaccine skeptic Robert F. Kennedy Jr. and the return of FDA vaccine regulator Vinay Prasad, who has advocated for tighter vaccine rules. Despite this setback, Moderna’s stock saw a slight dip, but the company expects approval for its flu shot by late 2026 or late 2027, pending international reviews.
Read More
The Food and Drug Administration (FDA) is cautioning consumers against purchasing certain cans of Genova Yellowfin Tuna due to potential contamination risks. These cans, which were part of a previous recall due to defective lids, were inadvertently shipped to several grocery store chains across nine states. The suspect cans, identified by specific UPC and code numbers, may contain clostridium botulinum, a dangerous form of food poisoning. Consumers are urged to discard the affected tuna products immediately or seek a refund from the point of purchase and to seek immediate medical attention if they feel unwell.
Read More
The FDA has recently approved two new oral antibiotics, zoliflodacin and gepotidacin, for the treatment of gonorrhea, marking the first new treatments in decades. These approvals come amid rising cases of gonorrhea and increasing antibiotic resistance to existing treatments. Both medications offer the advantage of oral administration, potentially improving patient access and convenience compared to the current injectable standard of care. Clinical trials demonstrated comparable efficacy and safety profiles for the new drugs.
Read More
The FDA is reportedly planning to issue “black box” warnings for COVID-19 vaccines, a move that has shocked outside experts. This plan, orchestrated by Dr. Vinay Prasad, is intended to warn about potential risks. This plan has sparked controversy due to the lack of transparency and a potential undermining of the vaccines’ safety, with many public health experts demanding supporting data. Critics worry this action may erode public trust in vaccines, potentially leading to unnecessary loss of life, especially since the move does not appear to follow established scientific processes.
Read More
Matt Underwood 
John Q. Hosedrinker